Europe Pulmonary Drug Delivery Devices Market Report 2018

SKU ID :XYZResearch -11901530 | Published Date: 30-Nov--0001 | No. of pages: 124
Table of Contents Europe Pulmonary Drug Delivery Devices Market Report 2012-2023 1 Pulmonary Drug Delivery Devices Overview 1.1 Product Overview and Scope of Pulmonary Drug Delivery Devices 1.2 Classification of Pulmonary Drug Delivery Devices by Product Category 1.2.1 Europe Pulmonary Drug Delivery Devices Sales (K Units) Comparison by Types (2012-2023) 1.2.2 Europe Pulmonary Drug Delivery Devices Sales (K Units) Market Share by Types in 2017 1.2.3 Dry Powder Inhaler 1.2.4 Metered Dose Inhaler 1.2.5 Nebulizer 1.3 Europe Pulmonary Drug Delivery Devices Market by Application/End Users 1.3.1 Europe Pulmonary Drug Delivery Devices (K Units) and Market Share Comparison by Applications (2012-2023) 1.3.2 Asthma 1.3.3 COPD 1.3.4 Cystic Fibrosis 1.3.5 Other 1.4 Europe Pulmonary Drug Delivery Devices Market by Region 1.4.1 Europe Pulmonary Drug Delivery Devices Revenue (Million USD) Comparison by Regions (2012-2023) 1.4.2 Germany Status and Prospect (2012-2023) 1.4.3 UK Status and Prospect (2012-2023) 1.4.4 France Status and Prospect (2012-2023) 1.4.5 Russia Status and Prospect (2012-2023) 1.4.6 Benelux Status and Prospect (2012-2023) 1.4.7 Italy Status and Prospect (2012-2023) 1.4.8 Spain Status and Prospect (2012-2023) 1.5 Europe Sales and Revenue ofSales and Revenue of Pulmonary Drug Delivery Devices (2012-2023) 1.5.1 Europe Pulmonary Drug Delivery Devices Sales (K Units) and Growth Rate (2012-2023) 1.5.2 Europe Pulmonary Drug Delivery Devices Revenue (Million USD) and Growth Rate (2012-2023) 2 Industrial Chain Analysis 2.1 Industry Chain Structure of Pulmonary Drug Delivery Devices 2.2 Raw Material Analysis of Pulmonary Drug Delivery Devices 2.1.1 Raw Material A Market Analysis 2.1.2 Raw Material B Market Analysis 2.1.3 Raw Material C Market Analysis 2.3 Labor Cost Analysis of Pulmonary Drug Delivery Devices 2.4 Other Costs Analysis of Pulmonary Drug Delivery Devices 2.5 Manufacturing Cost Structure Analysis of Pulmonary Drug Delivery Devices 2.6 Manufacturing Process Analysis of Pulmonary Drug Delivery Devices 2.7 Raw Materials Sources of Pulmonary Drug Delivery Devices Major Manufacturers in 2018 2.8 Downstream Buyers 3 Europe Pulmonary Drug Delivery Devices Players/Suppliers Profiles and Sales Data 3.1 Boehringer Ingelheim GmbH 3.1.1 Company Basic Information, Manufacturing Base and Competitors 3.1.2 Pulmonary Drug Delivery Devices Product Category, Application and Specification 3.1.2.1 Product A 3.1.2.2 Product B 3.1.3 Boehringer Ingelheim GmbH Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.1.4 Boehringer Ingelheim GmbH Different Types of Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.1.5 Boehringer Ingelheim GmbH Pulmonary Drug Delivery Devices Volume in Different Applications and Its Application Share 3.2 Novartis AG 3.2.1 Company Basic Information, Manufacturing Base and Competitors 3.2.2 Pulmonary Drug Delivery Devices Product Category, Application and Specification 3.2.2.1 Product A 3.2.2.2 Product B 3.2.3 Novartis AG Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.2.4 Novartis AG Different Types of Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.2.5 Novartis AG Pulmonary Drug Delivery Devices Volume in Different Applications and Its Application Share 3.3 GlaxoSmithKline 3.3.1 Company Basic Information, Manufacturing Base and Competitors 3.3.2 Pulmonary Drug Delivery Devices Product Category, Application and Specification 3.3.2.1 Product A 3.3.2.2 Product B 3.3.3 GlaxoSmithKline Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.3.4 GlaxoSmithKline Different Types of Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.3.5 GlaxoSmithKline Pulmonary Drug Delivery Devices Volume in Different Applications and Its Application Share 3.4 AstraZeneca 3.4.1 Company Basic Information, Manufacturing Base and Competitors 3.4.2 Pulmonary Drug Delivery Devices Product Category, Application and Specification 3.4.2.1 Product A 3.4.2.2 Product B 3.4.3 AstraZeneca Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.4.4 AstraZeneca Different Types of Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.4.5 AstraZeneca Pulmonary Drug Delivery Devices Volume in Different Applications and Its Application Share 3.5 Teva Pharmaceutical Industries 3.5.1 Company Basic Information, Manufacturing Base and Competitors 3.5.2 Pulmonary Drug Delivery Devices Product Category, Application and Specification 3.5.2.1 Product A 3.5.2.2 Product B 3.5.3 Teva Pharmaceutical Industries Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.5.4 Teva Pharmaceutical Industries Different Types of Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.5.5 Teva Pharmaceutical Industries Pulmonary Drug Delivery Devices Volume in Different Applications and Its Application Share 3.6 Merck 3.6.1 Company Basic Information, Manufacturing Base and Competitors 3.6.2 Pulmonary Drug Delivery Devices Product Category, Application and Specification 3.6.2.1 Product A 3.6.2.2 Product B 3.6.3 Merck Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.6.4 Merck Different Types of Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.6.5 Merck Pulmonary Drug Delivery Devices Volume in Different Applications and Its Application Share 3.7 MannKind 3.7.1 Company Basic Information, Manufacturing Base and Competitors 3.7.2 Pulmonary Drug Delivery Devices Product Category, Application and Specification 3.7.2.1 Product A 3.7.2.2 Product B 3.7.3 MannKind Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.7.4 MannKind Different Types of Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.7.5 MannKind Pulmonary Drug Delivery Devices Volume in Different Applications and Its Application Share 3.8 Bristol-Myers Squibb 3.8.1 Company Basic Information, Manufacturing Base and Competitors 3.8.2 Pulmonary Drug Delivery Devices Product Category, Application and Specification 3.8.2.1 Product A 3.8.2.2 Product B 3.8.3 Bristol-Myers Squibb Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.8.4 Bristol-Myers Squibb Different Types of Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.8.5 Bristol-Myers Squibb Pulmonary Drug Delivery Devices Volume in Different Applications and Its Application Share 3.9 Mylan N.V 3.9.1 Company Basic Information, Manufacturing Base and Competitors 3.9.2 Pulmonary Drug Delivery Devices Product Category, Application and Specification 3.9.2.1 Product A 3.9.2.2 Product B 3.9.3 Mylan N.V Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.9.4 Mylan N.V Different Types of Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.9.5 Mylan N.V Pulmonary Drug Delivery Devices Volume in Different Applications and Its Application Share 3.10 Omron Corp 3.10.1 Company Basic Information, Manufacturing Base and Competitors 3.10.2 Pulmonary Drug Delivery Devices Product Category, Application and Specification 3.10.2.1 Product A 3.10.2.2 Product B 3.10.3 Omron Corp Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.10.4 Omron Corp Different Types of Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.10.5 Omron Corp Pulmonary Drug Delivery Devices Volume in Different Applications and Its Application Share 3.11 F. Hoffmann-La Roche 3.12 3M Healthcare 3.13 Sunovion Pharmaceuticals 3.14 Koninklijke Philips N.V 3.15 Gerresheimer AG 4 Europe Pulmonary Drug Delivery Devices Competition by Players/Manufacturers, Region, Type and Application 4.1 Europe Pulmonary Drug Delivery Devices Market Competition by Players/Manufacturers 4.1.1 Europe Pulmonary Drug Delivery Devices Sales (K Units) and Market Share of Key Players/Suppliers (2012-2017) 4.1.2 Europe Pulmonary Drug Delivery Devices Revenue (Million USD) and Share by Players/Suppliers (2012-2017) 4.2 Europe Pulmonary Drug Delivery Devices Sales and Revenue by Type 4.2.1 Europe Pulmonary Drug Delivery Devices Sales (K Units) and Market Share by Type (2012-2017) 4.2.2 Europe Pulmonary Drug Delivery Devices Revenue (Million USD) and Market Share by Type (2012-2017) 4.3 Europe Pulmonary Drug Delivery Devices Sales and Revenue by Application 4.3.1 Europe Pulmonary Drug Delivery Devices Sales (K Units) and Market Share by Regions (2012-2017) 4.3.2 Europe Pulmonary Drug Delivery Devices Revenue (Million USD) and Market Share (%) Regions (2012-2017) 4.4 Europe Pulmonary Drug Delivery Devices Sales (K Units) by Application 5 Germany Pulmonary Drug Delivery Devices (Sales, Revenue and Price) 5.1 Germany Pulmonary Drug Delivery Devices Sales and Value (2012-2017) 5.1.1 Germany Pulmonary Drug Delivery Devices Sales (K Units) and Growth Rate (2012-2017) 5.1.2 Germany Pulmonary Drug Delivery Devices Revenue and Growth Rate (2012-2017) 5.1.3 Germany Pulmonary Drug Delivery Devices Sales Price (USD/Unit) Trend (2012-2017) 5.2 Germany Pulmonary Drug Delivery Devices Sales (K Units) and Market Share by Type 5.3 Germany Pulmonary Drug Delivery Devices Sales (K Units) and Market Share by Application 6 UK Pulmonary Drug Delivery Devices (Sales, Revenue and Price) 6.1 UK Pulmonary Drug Delivery Devices Sales and Value (2012-2017) 6.1.1 UK Pulmonary Drug Delivery Devices Sales (K Units) and Growth Rate (2012-2017) 6.1.2 UK Pulmonary Drug Delivery Devices Revenue and Growth Rate (2012-2017) 6.1.3 UK Pulmonary Drug Delivery Devices Sales Price (USD/Unit) Trend (2012-2017) 6.2 UK Pulmonary Drug Delivery Devices Sales (K Units) and Market Share by Type 6.3 UK Pulmonary Drug Delivery Devices Sales (K Units) and Market Share by Application 7 France Pulmonary Drug Delivery Devices (Sales, Revenue and Price) 7.1 France Pulmonary Drug Delivery Devices Sales and Value (2012-2017) 7.1.1 France Pulmonary Drug Delivery Devices Sales (K Units) and Growth Rate (2012-2017) 7.1.2 France Pulmonary Drug Delivery Devices Revenue and Growth Rate (2012-2017) 7.1.3 France Pulmonary Drug Delivery Devices Sales Price (USD/Unit) Trend (2012-2017) 7.2 France Pulmonary Drug Delivery Devices Sales (K Units) and Market Share by Type 7.3 France Pulmonary Drug Delivery Devices Sales (K Units) and Market Share by Application 8 Russia Pulmonary Drug Delivery Devices (Sales, Revenue and Price) 8.1 Russia Pulmonary Drug Delivery Devices Sales and Value (2012-2017) 8.1.1 Russia Pulmonary Drug Delivery Devices Sales (K Units) and Growth Rate (2012-2017) 8.1.2 Russia Pulmonary Drug Delivery Devices Revenue and Growth Rate (2012-2017) 8.1.3 Russia Pulmonary Drug Delivery Devices Sales Price (USD/Unit) Trend (2012-2017) 8.2 Russia Pulmonary Drug Delivery Devices Sales (K Units) and Market Share by Type 8.3 Russia Pulmonary Drug Delivery Devices Sales (K Units) and Market Share by Application 9 Benelux Pulmonary Drug Delivery Devices (Sales, Revenue and Price) 9.1 Benelux Pulmonary Drug Delivery Devices Sales and Value (2012-2017) 9.1.1 Benelux Pulmonary Drug Delivery Devices Sales (K Units) and Growth Rate (2012-2017) 9.1.2 Benelux Pulmonary Drug Delivery Devices Revenue and Growth Rate (2012-2017) 9.1.3 Benelux Pulmonary Drug Delivery Devices Sales Price (USD/Unit) Trend (2012-2017) 9.2 Benelux Pulmonary Drug Delivery Devices Sales (K Units) and Market Share by Type 9.3 Benelux Pulmonary Drug Delivery Devices Sales (K Units) and Market Share by Application 10 Italy Pulmonary Drug Delivery Devices (Sales, Revenue and Price) 10.1 Italy Pulmonary Drug Delivery Devices Sales and Value (2012-2017) 10.1.1 Italy Pulmonary Drug Delivery Devices Sales (K Units) and Growth Rate (2012-2017) 10.1.2 Italy Pulmonary Drug Delivery Devices Revenue and Growth Rate (2012-2017) 10.1.3 Italy Pulmonary Drug Delivery Devices Sales Price (USD/Unit) Trend (2012-2017) 10.2 Italy Pulmonary Drug Delivery Devices Sales (K Units) and Market Share by Type 10.3 Italy Pulmonary Drug Delivery Devices Sales (K Units) and Market Share by Application 11 Spain Pulmonary Drug Delivery Devices (Sales, Revenue and Price) 11.1 Spain Pulmonary Drug Delivery Devices Sales and Value (2012-2017) 11.1.1 Spain Pulmonary Drug Delivery Devices Sales (K Units) and Growth Rate (2012-2017) 11.1.2 Spain Pulmonary Drug Delivery Devices Revenue and Growth Rate (2012-2017) 11.1.3 Spain Pulmonary Drug Delivery Devices Sales Price (USD/Unit) Trend (2012-2017) 11.2 Spain Pulmonary Drug Delivery Devices Sales (K Units) and Market Share by Type 11.3 Spain Pulmonary Drug Delivery Devices Sales (K Units) and Market Share by Application 12 Marketing Strategy Analysis, Distributors/Traders 12.1 Direct Marketing 12.1.1 Direct Marketing 12.1.2 Indirect Marketing 12.1.3 Marketing Channel Development Trend 12.2 Market Positioning 12.2.1 Pricing Strategy 12.2.2 Brand Strategy 12.2.3 Target Client 12.3 Distributors/Traders List 13 Europe Pulmonary Drug Delivery Devices Market Forecast (2018-2023) 13.1 Europe Pulmonary Drug Delivery Devices Sales (K Units), Revenue and Price Forecast (2018-2023) 13.1.1 Europe Pulmonary Drug Delivery Devices Sales (K Units) and Growth Rate Forecast (2018-2023) 13.1.2 Europe Pulmonary Drug Delivery Devices Revenue and Growth Rate Forecast (2018-2023) 13.1.3 Europe Pulmonary Drug Delivery Devices Price and Trend Forecast (2018-2023) 13.2 Europe Pulmonary Drug Delivery Devices Sales (K Units), Revenue and Growth Rate Forecast by Region (2018-2023) 13.2.1 Europe Pulmonary Drug Delivery Devices Sales (K Units) and Growth Rate Forecast by Region (2018-2023) 13.2.2 Europe Pulmonary Drug Delivery Devices Revenue and Growth Rate Forecast by Region (2018-2023) 13.2.3 Germany Pulmonary Drug Delivery Devices Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.4 UK Pulmonary Drug Delivery Devices Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.5 France Pulmonary Drug Delivery Devices Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.6 Russia Pulmonary Drug Delivery Devices Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.7 France Pulmonary Drug Delivery Devices Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.8 Italy Pulmonary Drug Delivery Devices Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.9 Spain Pulmonary Drug Delivery Devices Sales, Revenue and Growth Rate Forecast (2018-2023) 13.3 Europe Pulmonary Drug Delivery Devices Sales, Revenue and Price Forecast by Type (2018-2023) 13.3.1 Europe Pulmonary Drug Delivery Devices Sales Forecast by Type (2018-2023) 13.3.2 Europe Pulmonary Drug Delivery Devices Revenue Forecast by Type (2018-2023) 13.3.3 Europe Pulmonary Drug Delivery Devices Price Forecast by Type (2018-2023) 13.4 Europe Pulmonary Drug Delivery Devices Sales Forecast by Application (2018-2023) 14 Research Findings and Conclusion 15 Appendix 15.1 Methodology/Research Approach 15.1.1 Research Programs/Design 15.1.2 Market Size Estimation 15.1.3 Market Breakdown and Data Triangulation 15.2 Data Source 15.2.1 Secondary Sources 15.2.2 Primary Sources 15.3 Disclaimer
List of Tables and Figures Figure Europe Market Size (Million USD) Comparison 2012-2023 Table Europe Market Pulmonary Drug Delivery Devices Revenue (Million USD) Comparison by Regions 2012-2023 Table Europe Pulmonary Drug Delivery Devices Sales (K Units) and Revenue (Million USD) Market Split by Product Type Table Europe Pulmonary Drug Delivery Devices Sales (K Units) by Application (2016-2023) Figure Product Picture of Pulmonary Drug Delivery Devices Table Europe Pulmonary Drug Delivery Devices Sales (K Units) and Growth Rate (%) Comparison by Types (2012-2023) Figure Europe Pulmonary Drug Delivery Devices Sales (K Units) Market Share by Types in 2017 Figure Dry Powder Inhaler Picture Figure Metered Dose Inhaler Picture Figure Nebulizer Picture Table Europe Pulmonary Drug Delivery Devices Sales (K Units) Comparison by Applications (2012-2023) Figure Europe Sales Market Share of Pulmonary Drug Delivery Devices by Applications in 2017 Figure Asthma Picture Figure COPD Picture Figure Cystic Fibrosis Picture Table Europe Market Pulmonary Drug Delivery Devices Revenue (Million USD) Comparison by Regions 2012-2023 Figure Germany Pulmonary Drug Delivery Devices Revenue (Million USD) and Growth Rate (2012-2023) Figure UK Pulmonary Drug Delivery Devices Revenue (Million USD) and Growth Rate (2012-2023) Figure France Pulmonary Drug Delivery Devices Revenue (Million USD) and Growth Rate (2012-2023) Figure Russia Pulmonary Drug Delivery Devices Revenue (Million USD) and Growth Rate (2012-2023) Figure Benelux Pulmonary Drug Delivery Devices Revenue (Million USD) and Growth Rate (2012-2023) Figure Italy Pulmonary Drug Delivery Devices Revenue (Million USD) and Growth Rate (2012-2023) Figure Spain Pulmonary Drug Delivery Devices Revenue (Million USD) and Growth Rate (2012-2023) Figure Europe Pulmonary Drug Delivery Devices Sales (K Units) and Growth Rate (2012-2023) Figure Europe Pulmonary Drug Delivery Devices Revenue (Million USD) and Growth Rate (2012-2023) Figure New Project SWOT Analysis of Pulmonary Drug Delivery Devices Table Industry News List of Pulmonary Drug Delivery Devices Figure Industry Chain Structure of Pulmonary Drug Delivery Devices Table Raw Material Suppliers and Price Analysis Figure Global Raw Material A Price Trend (USD/MT) Figure Global Raw Material B Price Trend (USD/MT) Figure Global Raw Material C Price Trend (USD/MT) Table Manufacturing Cost Structure Analysis of Pulmonary Drug Delivery Devices in 2017 Figure Manufacturing Process Analysis of Pulmonary Drug Delivery Devices Table Raw Materials Sources of Pulmonary Drug Delivery Devices Major Manufacturers Europe Table Major Buyers of Pulmonary Drug Delivery Devices Table Boehringer Ingelheim GmbH Basic Information List Table Boehringer Ingelheim GmbH Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Boehringer Ingelheim GmbH Pulmonary Drug Delivery Devices Sales Growth Rate (2012-2017) Figure Boehringer Ingelheim GmbH Pulmonary Drug Delivery Devices Sales Europe Market Share (%) (2012-2017) Figure Boehringer Ingelheim GmbH Pulmonary Drug Delivery Devices Revenue Europe Market Share (%) (2012-2017) Table Dry Powder Inhaler Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Metered Dose Inhaler Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Nebulizer Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Boehringer Ingelheim GmbH Pulmonary Drug Delivery Devices Volume in Asthma and Its Application Share Table Boehringer Ingelheim GmbH Pulmonary Drug Delivery Devices Volume in COPD and Its Application Share Table Boehringer Ingelheim GmbH Pulmonary Drug Delivery Devices Volume in Cystic Fibrosis and Its Application Share Table Novartis AG Basic Information List Table Novartis AG Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Novartis AG Pulmonary Drug Delivery Devices Sales Growth Rate (2012-2017) Figure Novartis AG Pulmonary Drug Delivery Devices Sales Europe Market Share (%) (2012-2017) Figure Novartis AG Pulmonary Drug Delivery Devices Revenue Europe Market Share (%) (2012-2017) Table Dry Powder Inhaler Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Metered Dose Inhaler Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Nebulizer Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Novartis AG Pulmonary Drug Delivery Devices Volume in Asthma and Its Application Share Table Novartis AG Pulmonary Drug Delivery Devices Volume in COPD and Its Application Share Table Novartis AG Pulmonary Drug Delivery Devices Volume in Cystic Fibrosis and Its Application Share Table GlaxoSmithKline Basic Information List Table GlaxoSmithKline Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure GlaxoSmithKline Pulmonary Drug Delivery Devices Sales Growth Rate (2012-2017) Figure GlaxoSmithKline Pulmonary Drug Delivery Devices Sales Europe Market Share (%) (2012-2017) Figure GlaxoSmithKline Pulmonary Drug Delivery Devices Revenue Europe Market Share (%) (2012-2017) Table Dry Powder Inhaler Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Metered Dose Inhaler Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Nebulizer Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table GlaxoSmithKline Pulmonary Drug Delivery Devices Volume in Asthma and Its Application Share Table GlaxoSmithKline Pulmonary Drug Delivery Devices Volume in COPD and Its Application Share Table GlaxoSmithKline Pulmonary Drug Delivery Devices Volume in Cystic Fibrosis and Its Application Share Table AstraZeneca Basic Information List Table AstraZeneca Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure AstraZeneca Pulmonary Drug Delivery Devices Sales Growth Rate (2012-2017) Figure AstraZeneca Pulmonary Drug Delivery Devices Sales Europe Market Share (%) (2012-2017) Figure AstraZeneca Pulmonary Drug Delivery Devices Revenue Europe Market Share (%) (2012-2017) Table Dry Powder Inhaler Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Metered Dose Inhaler Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Nebulizer Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table AstraZeneca Pulmonary Drug Delivery Devices Volume in Asthma and Its Application Share Table AstraZeneca Pulmonary Drug Delivery Devices Volume in COPD and Its Application Share Table AstraZeneca Pulmonary Drug Delivery Devices Volume in Cystic Fibrosis and Its Application Share Table Teva Pharmaceutical Industries Basic Information List Table Teva Pharmaceutical Industries Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Teva Pharmaceutical Industries Pulmonary Drug Delivery Devices Sales Growth Rate (2012-2017) Figure Teva Pharmaceutical Industries Pulmonary Drug Delivery Devices Sales Europe Market Share (%) (2012-2017) Figure Teva Pharmaceutical Industries Pulmonary Drug Delivery Devices Revenue Europe Market Share (%) (2012-2017) Table Dry Powder Inhaler Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Metered Dose Inhaler Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Nebulizer Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Teva Pharmaceutical Industries Pulmonary Drug Delivery Devices Volume in Asthma and Its Application Share Table Teva Pharmaceutical Industries Pulmonary Drug Delivery Devices Volume in COPD and Its Application Share Table Teva Pharmaceutical Industries Pulmonary Drug Delivery Devices Volume in Cystic Fibrosis and Its Application Share Table Merck Basic Information List Table Merck Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Merck Pulmonary Drug Delivery Devices Sales Growth Rate (2012-2017) Figure Merck Pulmonary Drug Delivery Devices Sales Europe Market Share (%) (2012-2017) Figure Merck Pulmonary Drug Delivery Devices Revenue Europe Market Share (%) (2012-2017) Table Dry Powder Inhaler Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Metered Dose Inhaler Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Nebulizer Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Merck Pulmonary Drug Delivery Devices Volume in Asthma and Its Application Share Table Merck Pulmonary Drug Delivery Devices Volume in COPD and Its Application Share Table Merck Pulmonary Drug Delivery Devices Volume in Cystic Fibrosis and Its Application Share Table MannKind Basic Information List Table MannKind Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure MannKind Pulmonary Drug Delivery Devices Sales Growth Rate (2012-2017) Figure MannKind Pulmonary Drug Delivery Devices Sales Europe Market Share (%) (2012-2017) Figure MannKind Pulmonary Drug Delivery Devices Revenue Europe Market Share (%) (2012-2017) Table Dry Powder Inhaler Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Metered Dose Inhaler Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Nebulizer Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table MannKind Pulmonary Drug Delivery Devices Volume in Asthma and Its Application Share Table MannKind Pulmonary Drug Delivery Devices Volume in COPD and Its Application Share Table MannKind Pulmonary Drug Delivery Devices Volume in Cystic Fibrosis and Its Application Share Table Bristol-Myers Squibb Basic Information List Table Bristol-Myers Squibb Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Bristol-Myers Squibb Pulmonary Drug Delivery Devices Sales Growth Rate (2012-2017) Figure Bristol-Myers Squibb Pulmonary Drug Delivery Devices Sales Europe Market Share (%) (2012-2017) Figure Bristol-Myers Squibb Pulmonary Drug Delivery Devices Revenue Europe Market Share (%) (2012-2017) Table Dry Powder Inhaler Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Metered Dose Inhaler Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Nebulizer Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Bristol-Myers Squibb Pulmonary Drug Delivery Devices Volume in Asthma and Its Application Share Table Bristol-Myers Squibb Pulmonary Drug Delivery Devices Volume in COPD and Its Application Share Table Bristol-Myers Squibb Pulmonary Drug Delivery Devices Volume in Cystic Fibrosis and Its Application Share Table Mylan N.V Basic Information List Table Mylan N.V Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Mylan N.V Pulmonary Drug Delivery Devices Sales Growth Rate (2012-2017) Figure Mylan N.V Pulmonary Drug Delivery Devices Sales Europe Market Share (%) (2012-2017) Figure Mylan N.V Pulmonary Drug Delivery Devices Revenue Europe Market Share (%) (2012-2017) Table Dry Powder Inhaler Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Metered Dose Inhaler Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Nebulizer Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Mylan N.V Pulmonary Drug Delivery Devices Volume in Asthma and Its Application Share Table Mylan N.V Pulmonary Drug Delivery Devices Volume in COPD and Its Application Share Table Mylan N.V Pulmonary Drug Delivery Devices Volume in Cystic Fibrosis and Its Application Share Table Company Omron Corp Basic Information List Table Company Omron Corp Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Company Omron Corp Pulmonary Drug Delivery Devices Sales Growth Rate (2012-2017) Figure Company Omron Corp Pulmonary Drug Delivery Devices Sales Europe Market Share (%) (2012-2017) Figure Company Omron Corp Pulmonary Drug Delivery Devices Revenue Europe Market Share (%) (2012-2017) Table Dry Powder Inhaler Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Metered Dose Inhaler Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Nebulizer Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Company Omron Corp Pulmonary Drug Delivery Devices Volume in Asthma and Its Application Share Table Company Omron Corp Pulmonary Drug Delivery Devices Volume in COPD and Its Application Share Table Company Omron Corp Pulmonary Drug Delivery Devices Volume in Cystic Fibrosis and Its Application Share Table Europe Pulmonary Drug Delivery Devices Sales (K Units) by Players/Manufacturers (2012-2017) Table Europe Pulmonary Drug Delivery Devices Sales Share (%) by Players/Manufacturers (2012-2017) Figure 2016 Europe Pulmonary Drug Delivery Devices Sales Market Share (%) by Players/Manufacturers Figure 2017 Europe Pulmonary Drug Delivery Devices Sales Share by Players/Manufacturers Table Europe Pulmonary Drug Delivery Devices Revenue (Million USD) by Players/Manufacturers (2012-2017) Table Europe Pulmonary Drug Delivery Devices Revenue Market Share (%) Players/Manufacturers (2012-2017) Figure 2016 Europe Pulmonary Drug Delivery Devices Revenue Market Share (%) Players Figure 2017 Europe Pulmonary Drug Delivery Devices Revenue Market Share (%) Players Table Europe Pulmonary Drug Delivery Devices Sales (K Units) and Market Share (%) by Type (2012-2017) Table Europe Pulmonary Drug Delivery Devices Sales Share by Type (2012-2017) Figure Sales Market Share of Pulmonary Drug Delivery Devices by Type (2012-2017) Figure Europe Pulmonary Drug Delivery Devices Sales Growth Rate (%) by Type (2012-2017) Table Europe Pulmonary Drug Delivery Devices Revenue (Million USD) and Market Share (%) Type (2012-2017) Table Europe Pulmonary Drug Delivery Devices Revenue Market Share (%) Type (2012-2017) Figure Revenue Market Share of Pulmonary Drug Delivery Devices by Type (2012-2017) Figure Europe Pulmonary Drug Delivery Devices Revenue Growth Rate by Type (2012-2017) Table Europe Pulmonary Drug Delivery Devices Sales (K Units) and Market Share by Regions (2012-2017) Table Europe Pulmonary Drug Delivery Devices Sales Share by Regions (2012-2017) Figure Sales Market Share of Pulmonary Drug Delivery Devices by Regions (2012-2017) Figure Europe Pulmonary Drug Delivery Devices Sales Market Share by Regions in 2017 Table Europe Pulmonary Drug Delivery Devices Revenue (Million USD) and Market Share by Regions (2012-2017) Table Europe Pulmonary Drug Delivery Devices Revenue Share (%) by Regions (2012-2017) Figure Revenue Market Share of Pulmonary Drug Delivery Devices by Regions (2012-2017) Figure Europe Pulmonary Drug Delivery Devices Revenue Market Share by Regions in 2017 Table Europe Pulmonary Drug Delivery Devices Sales (K Units) and Market Share by Application (2012-2017) Table Europe Pulmonary Drug Delivery Devices Sales Share (%) by Application (2012-2017) Figure Europe Pulmonary Drug Delivery Devices Sales Market Share by Application (2012-2017) Figure Europe Pulmonary Drug Delivery Devices Sales Market Share by Application (2012-2017) Figure Germany Pulmonary Drug Delivery Devices Sales (K Units) and Growth Rate (%) (2012-2017) Figure Germany Pulmonary Drug Delivery Devices Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Germany Pulmonary Drug Delivery Devices Sales Price (USD/Unit) Trend (2012-2017) Table Germany Pulmonary Drug Delivery Devices Sales (K Units) by Type (2012-2017) Table Germany Pulmonary Drug Delivery Devices Sales (K Units) Market Share by Type (2012-2017) Figure Germany Pulmonary Drug Delivery Devices Sales (K Units) Market Share by Type in 2017 Table Germany Pulmonary Drug Delivery Devices Sales (K Units) by Applications (2012-2017) Table Germany Pulmonary Drug Delivery Devices Sales (K Units) Market Share by Applications (2012-2017) Figure Germany Pulmonary Drug Delivery Devices Sales (K Units) Market Share by Applications in 2017 Figure UK Pulmonary Drug Delivery Devices Sales (K Units) and Growth Rate (2012-2017) Figure UK Pulmonary Drug Delivery Devices Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure UK Pulmonary Drug Delivery Devices Sales Price (USD/Unit) Trend (2012-2017) Table UK Pulmonary Drug Delivery Devices Sales (K Units) by Type (2012-2017) Table UK Pulmonary Drug Delivery Devices Sales (K Units) Market Share by Type (2012-2017) Figure UK Pulmonary Drug Delivery Devices Sales (K Units) Market Share by Type in 2017 Table UK Pulmonary Drug Delivery Devices Sales (K Units) by Applications (2012-2017) Table UK Pulmonary Drug Delivery Devices Sales (K Units) Market Share by Applications (2012-2017) Figure UK Pulmonary Drug Delivery Devices Sales (K Units) Market Share by Applications in 2017 Figure France Pulmonary Drug Delivery Devices Sales (K Units) and Growth Rate (2012-2017) Figure France Pulmonary Drug Delivery Devices Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure France Pulmonary Drug Delivery Devices Sales Price (USD/Unit) Trend (2012-2017) Table France Pulmonary Drug Delivery Devices Sales (K Units) by Type (2012-2017) Table France Pulmonary Drug Delivery Devices Sales (K Units) Market Share by Type (2012-2017) Figure France Pulmonary Drug Delivery Devices Sales (K Units) Market Share by Type in 2017 Table France Pulmonary Drug Delivery Devices Sales (K Units) by Applications (2012-2017) Table France Pulmonary Drug Delivery Devices Sales (K Units) Market Share by Applications (2012-2017) Figure France Pulmonary Drug Delivery Devices Sales (K Units) Market Share by Applications in 2017 Figure Russia Pulmonary Drug Delivery Devices Sales (K Units) and Growth Rate (2012-2017) Figure Russia Pulmonary Drug Delivery Devices Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Russia Pulmonary Drug Delivery Devices Sales Price (USD/Unit) Trend (2012-2017) Table Russia Pulmonary Drug Delivery Devices Sales (K Units) by Type (2012-2017) Table Russia Pulmonary Drug Delivery Devices Sales (K Units) Market Share by Type (2012-2017) Figure Russia Pulmonary Drug Delivery Devices Sales (K Units) Market Share by Type in 2017 Table Russia Pulmonary Drug Delivery Devices Sales (K Units) by Applications (2012-2017) Table Russia Pulmonary Drug Delivery Devices Sales (K Units) Market Share by Applications (2012-2017) Figure Russia Pulmonary Drug Delivery Devices Sales (K Units) Market Share by Applications in 2017 Figure Italy Pulmonary Drug Delivery Devices Sales (K Units) and Growth Rate (2012-2017) Figure Italy Pulmonary Drug Delivery Devices Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Italy Pulmonary Drug Delivery Devices Sales Price (USD/Unit) Trend (2012-2017) Table Italy Pulmonary Drug Delivery Devices Sales (K Units) by Type (2012-2017) Table Italy Pulmonary Drug Delivery Devices Sales (K Units) Market Share by Type (2012-2017) Figure Italy Pulmonary Drug Delivery Devices Sales (K Units) Market Share by Type in 2017 Table Italy Pulmonary Drug Delivery Devices Sales (K Units) by Applications (2012-2017) Table Italy Pulmonary Drug Delivery Devices Sales (K Units) Market Share by Applications (2012-2017) Figure Italy Pulmonary Drug Delivery Devices Sales (K Units) Market Share by Applications in 2017 Figure Benelux Pulmonary Drug Delivery Devices Sales (K Units) and Growth Rate (2012-2017) Figure Benelux Pulmonary Drug Delivery Devices Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Benelux Pulmonary Drug Delivery Devices Sales Price (USD/Unit) Trend (2012-2017) Table Benelux Pulmonary Drug Delivery Devices Sales (K Units) by Type (2012-2017) Table Benelux Pulmonary Drug Delivery Devices Sales (K Units) Market Share by Type (2012-2017) Figure Benelux Pulmonary Drug Delivery Devices Sales (K Units) Market Share by Type in 2017 Table Benelux Pulmonary Drug Delivery Devices Sales (K Units) by Applications (2012-2017) Table Benelux Pulmonary Drug Delivery Devices Sales (K Units) Market Share by Applications (2012-2017) Figure Benelux Pulmonary Drug Delivery Devices Sales (K Units) Market Share by Applications in 2017 Figure Spain Pulmonary Drug Delivery Devices Sales (K Units) and Growth Rate (2012-2017) Figure Spain Pulmonary Drug Delivery Devices Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Spain Pulmonary Drug Delivery Devices Sales Price (USD/Unit) Trend (2012-2017) Table Spain Pulmonary Drug Delivery Devices Sales (K Units) by Type (2012-2017) Table Spain Pulmonary Drug Delivery Devices Sales (K Units) Market Share by Type (2012-2017) Figure Spain Pulmonary Drug Delivery Devices Sales (K Units) Market Share by Type in 2017 Table Spain Pulmonary Drug Delivery Devices Sales (K Units) by Applications (2012-2017) Table Spain Pulmonary Drug Delivery Devices Sales (K Units) Market Share by Applications (2012-2017) Figure Spain Pulmonary Drug Delivery Devices Sales (K Units) Market Share by Applications in 2017 Table Distributors/Traders List Figure Europe Pulmonary Drug Delivery Devices Sales (K Units) and Growth Rate Forecast (2018-2023) Figure Europe Pulmonary Drug Delivery Devices Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Europe Pulmonary Drug Delivery Devices Price and Trend Forecast (2018-2023) Table Europe Pulmonary Drug Delivery Devices Sales (K Units) Forecast by Regions (2018-2023) Figure Europe Pulmonary Drug Delivery Devices Sales (K Units) Market Share Forecast by Regions (2018-2023) Figure Europe Pulmonary Drug Delivery Devices Sales (K Units) Market Share Forecast by Regions in 2023 Table Europe Pulmonary Drug Delivery Devices Revenue (Million USD) Forecast by Regions (2018-2023) Figure Europe Pulmonary Drug Delivery Devices Revenue Market Share Forecast by Regions (2018-2023) Figure Europe Pulmonary Drug Delivery Devices Revenue Market Share Forecast by Regions in 2023 Figure Germany Pulmonary Drug Delivery Devices Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Germany Pulmonary Drug Delivery Devices Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure France Pulmonary Drug Delivery Devices Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure France Pulmonary Drug Delivery Devices Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure UK Pulmonary Drug Delivery Devices Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure UK Pulmonary Drug Delivery Devices Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Russia Pulmonary Drug Delivery Devices Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Russia Pulmonary Drug Delivery Devices Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Benelux Pulmonary Drug Delivery Devices Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Benelux Pulmonary Drug Delivery Devices Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Italy Pulmonary Drug Delivery Devices Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Italy Pulmonary Drug Delivery Devices Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Spain Pulmonary Drug Delivery Devices Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Spain Pulmonary Drug Delivery Devices Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Table Europe Pulmonary Drug Delivery Devices Sales (K Units) Forecast by Type (2018-2023) Figure Europe Pulmonary Drug Delivery Devices Sales Market Share Forecast by Type (2018-2023) Table Europe Pulmonary Drug Delivery Devices Revenue (Million USD) Forecast by Type (2018-2023) Figure Europe Pulmonary Drug Delivery Devices Revenue Market Share Forecast by Type (2018-2023) Table Europe Pulmonary Drug Delivery Devices Price (USD/Unit) Forecast by Type (2018-2023) Table Europe Pulmonary Drug Delivery Devices Sales (K Units) Forecast by Application (2018-2023) Figure Europe Pulmonary Drug Delivery Devices Sales Market Share Forecast by Application (2018-2023) Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources
Boehringer Ingelheim GmbH Novartis AG GlaxoSmithKline AstraZeneca Teva Pharmaceutical Industries Merck MannKind Bristol-Myers Squibb Mylan N.V Omron Corp F. Hoffmann-La Roche 3M Healthcare Sunovion Pharmaceuticals Koninklijke Philips N.V Gerresheimer AG
  • PRICE
  • $3450
    $6800

Our Clients